Insights

Cutting-edge technology Saluda Medical utilizes advanced closed-loop technologies in their Evoke System for spinal cord stimulation, providing superior pain management solutions compared to traditional open-loop systems. This technology differentiation can be leveraged to attract customers looking for innovative and effective neuromodulation therapies.

Strategic funding Recent significant investments totaling $150M from reputable firms like T. Rowe Price, Fidelity, and Action Potential Venture Capital showcase confidence in Saluda Medical's growth potential. This financial backing can signal stability to potential clients and partners, making the company an attractive choice for collaboration or procurement.

Clinical validation The EVOKE Study, a double-blind randomized controlled trial supporting the Premarket Approval of the Evoke System, has published groundbreaking results in prestigious medical journals like The Lancet Neurology and JAMA Neurology. These clinical validations establish Saluda Medical as a credible provider of long-term pain relief solutions, appealing to healthcare providers seeking evidence-based treatment options.

Global expansion Despite being headquartered in the USA, Saluda Medical's CE Mark for Evoke in the EU and FDA approval in the U.S. position the company for international market penetration. Access to a wider geographic client base can lead to increased sales opportunities and partnerships with healthcare institutions looking to offer cutting-edge neuromodulation treatments.

Competitive landscape Comparative analysis with similar companies like Medtronic and NeuroPace, who operate in the neuromodulation space, can provide insights into competitor strategies and market positioning. Understanding the competitive landscape can help Saluda Medical's sales teams differentiate their offerings effectively and tailor sales pitches to showcase unique value propositions.

Saluda Medical Tech Stack

Saluda Medical uses 8 technology products and services including Google Font API, ADP, Microsoft SignalR, and more. Explore Saluda Medical's tech stack below.

  • Google Font API
    Font Scripts
  • ADP
    Human Resource Management System
  • Microsoft SignalR
    Javascript Frameworks
  • Angular
    Javascript Frameworks
  • Clipboard.js
    Javascript Libraries
  • Glassdoor
    Online Review Management
  • Python
    Programming Languages
  • Nginx
    Web Servers

Media & News

Saluda Medical's Email Address Formats

Saluda Medical uses at least 1 format(s):
Saluda Medical Email FormatsExamplePercentage
First.Last@saludamedical.comJohn.Doe@saludamedical.com
97%
First.Middle@saludamedical.comJohn.Michael@saludamedical.com
1%
First.Middle.Last@saludamedical.comJohn.Michael.Doe@saludamedical.com
1%
First.MiddleLast@saludamedical.comJohn.MichaelDoe@saludamedical.com
1%

Frequently Asked Questions

Where is Saluda Medical's headquarters located?

Minus sign iconPlus sign icon
Saluda Medical's main headquarters is located at 9401 James Ave S Suite 132 Bloomington, Minnesota 55431 US. The company has employees across 6 continents, including North AmericaOceaniaEurope.

What is Saluda Medical's official website and social media links?

Minus sign iconPlus sign icon
Saluda Medical's official website is saludamedical.com and has social profiles on LinkedIn.

How much revenue does Saluda Medical generate?

Minus sign iconPlus sign icon
As of October 2024, Saluda Medical's annual revenue reached $35M.

What is Saluda Medical's NAICS code?

Minus sign iconPlus sign icon
Saluda Medical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Saluda Medical have currently?

Minus sign iconPlus sign icon
As of October 2024, Saluda Medical has approximately 457 employees across 6 continents, including North AmericaOceaniaEurope. Key team members include Chief Clinical And Regulatory Officer: S. M.Chief Strategy Officer (cso): D. B.Chief Legal Officer: K. C.. Explore Saluda Medical's employee directory with LeadIQ.

What industry does Saluda Medical belong to?

Minus sign iconPlus sign icon
Saluda Medical operates in the Medical Equipment Manufacturing industry.

What technology does Saluda Medical use?

Minus sign iconPlus sign icon
Saluda Medical's tech stack includes Google Font APIADPMicrosoft SignalRAngularClipboard.jsGlassdoorPythonNginx.

What is Saluda Medical's email format?

Minus sign iconPlus sign icon
Saluda Medical's email format typically follows the pattern of . Find more Saluda Medical email formats with LeadIQ.

How much funding has Saluda Medical raised to date?

Minus sign iconPlus sign icon
As of October 2024, Saluda Medical has raised $150M in funding. The last funding round occurred on Apr 13, 2023 for $150M.

When was Saluda Medical founded?

Minus sign iconPlus sign icon
Saluda Medical was founded in 2011.
Saluda Medical

Saluda Medical

Medical Equipment ManufacturingMinnesota, United States201-500 Employees

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. 

The Evoke System instantaneously reads, records, and responds to the nerves’ response to stimulation to provide continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. 12-month results from the EVOKE Study, the first double-blind randomized controlled trial (RCT) used in support of Premarket Approval (PMA) in spinal cord stimulation history, were published in The Lancet Neurology and 24-month results have since been published JAMA Neurology. Both studies are poised to set new clinical standards for long-term pain relief and improvements in physical and emotional functioning, sleep quality and health-related quality of life. 

In the EU, Evoke is CE Marked and commercially available. In the U.S., Evoke is FDA-approved and will be available when the Company implements its full commercial release in 2023.

Saluda Medical is a privately held company with headquarters in Bloomington, MN, USA.  To learn more about Saluda Medical, including the risks & important safety information, visit www.saludamedical.com.

Section iconCompany Overview

Headquarters
9401 James Ave S Suite 132 Bloomington, Minnesota 55431 US
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2011
Employees
201-500

Section iconFunding & Financials

  • $150M

    Saluda Medical has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Apr 13, 2023 in the amount of $150M.

  • $10M$50M

    Saluda Medical's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $150M

    Saluda Medical has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Apr 13, 2023 in the amount of $150M.

  • $10M$50M

    Saluda Medical's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.